SEC Tracker
Get the app

Medicus Pharma MDCX

Medicus Pharma announces SPAC deal for SkinJect

Merger communication

Form
425
Filed
Importance
Routine
  1. CD228V designated as principal development priority
  2. Proposed SPAC business combination valued at ~$135 million
  3. Cash and cash equivalents: $5.0 million as of September 30, 2026

Written from the 425 on EDGAR. AI can make mistakes. Check the filing.

Open in the appGet the appView on EDGAR

Get an email when Medicus Pharma files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Champions Oncology CSBR public float $29M, Oct 31, 2025
  2. OnKure Therapeutics OKUR public float $28M, Jun 30, 2025
  3. Rockwell Medical RMTI public float $29M, Jun 30, 2025
  4. Cumberland Pharmaceuticals CPIX public float $29M, Jun 30, 2025
  5. ProMIS Neurosciences PMN public float $30M, Jun 30, 2025

Data on this page was fetched . The filing on SEC.gov is the record.